The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Docetaxel for Injection Market Research Report 2024

Global Docetaxel for Injection Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1763422

No of Pages : 109

Ask Your Query

Synopsis
Global Docetaxel for Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Docetaxel for Injection market research.

Key manufacturers engaged in the Docetaxel for Injection industry include Aventis Pharma S.A., Sanofi, Accord Healthcare, AuroMedics Pharma, Fresenius Kabi, GLS Pharma, Hikma, Hospira and Teikoku Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Docetaxel for Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Docetaxel for Injection market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Docetaxel for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Aventis Pharma S.A.
  • Sanofi
  • Accord Healthcare
  • AuroMedics Pharma
  • Fresenius Kabi
  • GLS Pharma
  • Hikma
  • Hospira
  • Teikoku Pharma
  • QILU Pharmaceutical
  • Shenzhen Main Luck Pharmaceuticals
  • Cisen Pharmaceutical
  • Shanghai Acebright Pharmaceuticals
  • Jiangsu Hengrui Pharmaceuticals
  • Yangtze River Pharmaceutical
  • Jiangsu Chia Tai-Tianqing Pharmaceutical

Segment by Type

  • 10mg/ml
  • 20mg/ml
  • 30mg/ml
  • Others

Segment by Application

  • Hospital
  • Clinic

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Docetaxel for Injection report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Docetaxel for Injection Market Overview
1.1 Product Overview and Scope of Docetaxel for Injection
1.2 Docetaxel for Injection Segment by Type
1.2.1 Global Docetaxel for Injection Market Value Comparison by Type (2023-2029)
1.2.2 10mg/ml
1.2.3 20mg/ml
1.2.4 30mg/ml
1.2.5 Others
1.3 Docetaxel for Injection Segment by Application
1.3.1 Global Docetaxel for Injection Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Docetaxel for Injection Market Size Estimates and Forecasts
1.4.1 Global Docetaxel for Injection Revenue 2018-2029
1.4.2 Global Docetaxel for Injection Sales 2018-2029
1.4.3 Global Docetaxel for Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Docetaxel for Injection Market Competition by Manufacturers
2.1 Global Docetaxel for Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Docetaxel for Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Docetaxel for Injection Average Price by Manufacturers (2018-2023)
2.4 Global Docetaxel for Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Docetaxel for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Docetaxel for Injection, Product Type & Application
2.7 Docetaxel for Injection Market Competitive Situation and Trends
2.7.1 Docetaxel for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Docetaxel for Injection Players Market Share by Revenue
2.7.3 Global Docetaxel for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Docetaxel for Injection Retrospective Market Scenario by Region
3.1 Global Docetaxel for Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Docetaxel for Injection Global Docetaxel for Injection Sales by Region: 2018-2029
3.2.1 Global Docetaxel for Injection Sales by Region: 2018-2023
3.2.2 Global Docetaxel for Injection Sales by Region: 2024-2029
3.3 Global Docetaxel for Injection Global Docetaxel for Injection Revenue by Region: 2018-2029
3.3.1 Global Docetaxel for Injection Revenue by Region: 2018-2023
3.3.2 Global Docetaxel for Injection Revenue by Region: 2024-2029
3.4 North America Docetaxel for Injection Market Facts & Figures by Country
3.4.1 North America Docetaxel for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Docetaxel for Injection Sales by Country (2018-2029)
3.4.3 North America Docetaxel for Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Docetaxel for Injection Market Facts & Figures by Country
3.5.1 Europe Docetaxel for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Docetaxel for Injection Sales by Country (2018-2029)
3.5.3 Europe Docetaxel for Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Docetaxel for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Docetaxel for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Docetaxel for Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Docetaxel for Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Docetaxel for Injection Market Facts & Figures by Country
3.7.1 Latin America Docetaxel for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Docetaxel for Injection Sales by Country (2018-2029)
3.7.3 Latin America Docetaxel for Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Docetaxel for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Docetaxel for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Docetaxel for Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Docetaxel for Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Docetaxel for Injection Sales by Type (2018-2029)
4.1.1 Global Docetaxel for Injection Sales by Type (2018-2023)
4.1.2 Global Docetaxel for Injection Sales by Type (2024-2029)
4.1.3 Global Docetaxel for Injection Sales Market Share by Type (2018-2029)
4.2 Global Docetaxel for Injection Revenue by Type (2018-2029)
4.2.1 Global Docetaxel for Injection Revenue by Type (2018-2023)
4.2.2 Global Docetaxel for Injection Revenue by Type (2024-2029)
4.2.3 Global Docetaxel for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Docetaxel for Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Docetaxel for Injection Sales by Application (2018-2029)
5.1.1 Global Docetaxel for Injection Sales by Application (2018-2023)
5.1.2 Global Docetaxel for Injection Sales by Application (2024-2029)
5.1.3 Global Docetaxel for Injection Sales Market Share by Application (2018-2029)
5.2 Global Docetaxel for Injection Revenue by Application (2018-2029)
5.2.1 Global Docetaxel for Injection Revenue by Application (2018-2023)
5.2.2 Global Docetaxel for Injection Revenue by Application (2024-2029)
5.2.3 Global Docetaxel for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Docetaxel for Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aventis Pharma S.A.
6.1.1 Aventis Pharma S.A. Corporation Information
6.1.2 Aventis Pharma S.A. Description and Business Overview
6.1.3 Aventis Pharma S.A. Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aventis Pharma S.A. Docetaxel for Injection Product Portfolio
6.1.5 Aventis Pharma S.A. Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi Docetaxel for Injection Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Accord Healthcare
6.3.1 Accord Healthcare Corporation Information
6.3.2 Accord Healthcare Description and Business Overview
6.3.3 Accord Healthcare Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Accord Healthcare Docetaxel for Injection Product Portfolio
6.3.5 Accord Healthcare Recent Developments/Updates
6.4 AuroMedics Pharma
6.4.1 AuroMedics Pharma Corporation Information
6.4.2 AuroMedics Pharma Description and Business Overview
6.4.3 AuroMedics Pharma Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AuroMedics Pharma Docetaxel for Injection Product Portfolio
6.4.5 AuroMedics Pharma Recent Developments/Updates
6.5 Fresenius Kabi
6.5.1 Fresenius Kabi Corporation Information
6.5.2 Fresenius Kabi Description and Business Overview
6.5.3 Fresenius Kabi Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Fresenius Kabi Docetaxel for Injection Product Portfolio
6.5.5 Fresenius Kabi Recent Developments/Updates
6.6 GLS Pharma
6.6.1 GLS Pharma Corporation Information
6.6.2 GLS Pharma Description and Business Overview
6.6.3 GLS Pharma Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GLS Pharma Docetaxel for Injection Product Portfolio
6.6.5 GLS Pharma Recent Developments/Updates
6.7 Hikma
6.6.1 Hikma Corporation Information
6.6.2 Hikma Description and Business Overview
6.6.3 Hikma Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hikma Docetaxel for Injection Product Portfolio
6.7.5 Hikma Recent Developments/Updates
6.8 Hospira
6.8.1 Hospira Corporation Information
6.8.2 Hospira Description and Business Overview
6.8.3 Hospira Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hospira Docetaxel for Injection Product Portfolio
6.8.5 Hospira Recent Developments/Updates
6.9 Teikoku Pharma
6.9.1 Teikoku Pharma Corporation Information
6.9.2 Teikoku Pharma Description and Business Overview
6.9.3 Teikoku Pharma Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Teikoku Pharma Docetaxel for Injection Product Portfolio
6.9.5 Teikoku Pharma Recent Developments/Updates
6.10 QILU Pharmaceutical
6.10.1 QILU Pharmaceutical Corporation Information
6.10.2 QILU Pharmaceutical Description and Business Overview
6.10.3 QILU Pharmaceutical Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 QILU Pharmaceutical Docetaxel for Injection Product Portfolio
6.10.5 QILU Pharmaceutical Recent Developments/Updates
6.11 Shenzhen Main Luck Pharmaceuticals
6.11.1 Shenzhen Main Luck Pharmaceuticals Corporation Information
6.11.2 Shenzhen Main Luck Pharmaceuticals Docetaxel for Injection Description and Business Overview
6.11.3 Shenzhen Main Luck Pharmaceuticals Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shenzhen Main Luck Pharmaceuticals Docetaxel for Injection Product Portfolio
6.11.5 Shenzhen Main Luck Pharmaceuticals Recent Developments/Updates
6.12 Cisen Pharmaceutical
6.12.1 Cisen Pharmaceutical Corporation Information
6.12.2 Cisen Pharmaceutical Docetaxel for Injection Description and Business Overview
6.12.3 Cisen Pharmaceutical Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Cisen Pharmaceutical Docetaxel for Injection Product Portfolio
6.12.5 Cisen Pharmaceutical Recent Developments/Updates
6.13 Shanghai Acebright Pharmaceuticals
6.13.1 Shanghai Acebright Pharmaceuticals Corporation Information
6.13.2 Shanghai Acebright Pharmaceuticals Docetaxel for Injection Description and Business Overview
6.13.3 Shanghai Acebright Pharmaceuticals Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shanghai Acebright Pharmaceuticals Docetaxel for Injection Product Portfolio
6.13.5 Shanghai Acebright Pharmaceuticals Recent Developments/Updates
6.14 Jiangsu Hengrui Pharmaceuticals
6.14.1 Jiangsu Hengrui Pharmaceuticals Corporation Information
6.14.2 Jiangsu Hengrui Pharmaceuticals Docetaxel for Injection Description and Business Overview
6.14.3 Jiangsu Hengrui Pharmaceuticals Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Jiangsu Hengrui Pharmaceuticals Docetaxel for Injection Product Portfolio
6.14.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.15 Yangtze River Pharmaceutical
6.15.1 Yangtze River Pharmaceutical Corporation Information
6.15.2 Yangtze River Pharmaceutical Docetaxel for Injection Description and Business Overview
6.15.3 Yangtze River Pharmaceutical Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Yangtze River Pharmaceutical Docetaxel for Injection Product Portfolio
6.15.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.16 Jiangsu Chia Tai-Tianqing Pharmaceutical
6.16.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Corporation Information
6.16.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Docetaxel for Injection Description and Business Overview
6.16.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Docetaxel for Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Docetaxel for Injection Product Portfolio
6.16.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Docetaxel for Injection Industry Chain Analysis
7.2 Docetaxel for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Docetaxel for Injection Production Mode & Process
7.4 Docetaxel for Injection Sales and Marketing
7.4.1 Docetaxel for Injection Sales Channels
7.4.2 Docetaxel for Injection Distributors
7.5 Docetaxel for Injection Customers
8 Docetaxel for Injection Market Dynamics
8.1 Docetaxel for Injection Industry Trends
8.2 Docetaxel for Injection Market Drivers
8.3 Docetaxel for Injection Market Challenges
8.4 Docetaxel for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock